pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,755 catalysts · 3,152 8k filing · 1,702 grant · 1,000 device adverse event · 795 approval · 621 device 510k · 584 earnings

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 45 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-02-06×clear all
type
  • 8k filing3,152
  • grant1,702
  • device adverse event1,000
  • approval795
  • device 510k621
  • earnings584
device pma
467
  • device recall191
  • phase 2 completion172
  • recall162
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Feb 16, 2026

    50
    ›Feb 16, 2026device recall178d agoMedline Industries, LP device recall (Cls II)

    Medline convenience kits containing Olympus biopsy valves: 1. BRONCH PACK, DYKE2096 2. NON MB BRONCHOPSCOPY CCH LH PK, DYNJT6182 3. PULMONARY BRONCH PACK, DYNDA2861A — Reason: Kits contain recalled Olympus biopsy valves. Olympus is investigating an increase in complaints associated with rubber fragment detachment in the slit of single use biopsy valves. Potential consequences associated with detachment of fragments from valve include foreign body in patient's tracheobronchial tree, which may require intervention for removal. Other potential consequences include inflammatory response, hypoxia, and prolongation of procedure. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 16, 2026device recall178d agoConvaTec, Inc device recall (Cls II)

    Convatec, EsteemBody Drainable Pouch REF:423657 10-35mm — Reason: Drainable large pouch may leak due to manufacturing issue. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 16, 2026device recall178d agoMedline Industries, LP device recall (Cls II)

    Medline kits containing Olympus biopsy valves: 1. BAL KIT, DYNDA2137B 2. ENDO KIT, DYKE1915 — Reason: Kits contain recalled Olympus biopsy valves. Olympus is investigating an increase in complaints associated with rubber fragment detachment in the slit of single use biopsy valves. Potential consequences associated with detachment of fragments from valve include foreign body in patient's tracheobronchial tree, which may require intervention for removal. Other potential consequences include inflammatory response, hypoxia, and prolongation of procedure. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 16, 2026device recall178d agoMedline Industries, LP device recall (Cls II)

    MEDLINE ANTERIOR HIP PACK DYNJ64672B — Reason: Kits contain recalled Olympus biopsy valves. Olympus is investigating an increase in complaints associated with rubber fragment detachment in the slit of single use biopsy valves. Potential consequences associated with detachment of fragments from valve include foreign body in patient's tracheobronchial tree, which may require intervention for removal. Other potential consequences include inflammatory response, hypoxia, and prolongation of procedure. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 16, 2026grant178d agoUNIVERSITY OF WISCONSIN-MADISON — miRNA degradation in post-stroke brain

    NS grant. $494,240. PI: Suresh L Mehta

    full page →nih reporter ↗
    ›Feb 16, 2026grant178d agoVANDERBILT UNIVERSITY MEDICAL CENTER — Genetic variant Evidence using Novel tools to Elucidate Pathophysiology: Acce...

    HG grant. $1,193,092. PI: Jada Benn Torres

    full page →nih reporter ↗
    ›Feb 16, 2026grant178d agoBAYLOR COLLEGE OF MEDICINE — Osteoclast Dysfunction in Lysinuric Protein Intolerance (LPI)Baylor College of Medicine

    HD grant. $50,526. PI: Cher Sha

    full page →nih reporter ↗
    ›Feb 16, 2026grant178d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Exploring Cholinergic Changes and their Associations with Sleep Alterations i...

    NS grant. $128,358. PI: Giulia Carli

    full page →nih reporter ↗
    ›Feb 16, 2026grant178d agoNEW YORK UNIVERSITY SCHOOL OF MEDICINE — The NYU-Sage NAMs Data Hub and Coordinating Center: Harmonizing, Analyzing, a...New York University

    ES grant. $5,000,000. PI: Jineta Banerjee

    full page →nih reporter ↗
    ›Feb 16, 2026grant178d agoMEDICAL UNIVERSITY OF SOUTH CAROLINA — Epigenetic Regulation of Pre-and Post-Translational Signaling in Aortic Valve...

    HL grant. $247,600. PI: Cassandra Lucille Clift

    full page →nih reporter ↗
    ›Feb 16, 2026grant178d agoUNIVERSITY OF COLORADO DENVER — Biogenesis of hERG1a/1b ion channels in health and disease model cardiomyocytesUniversity of Colorado Denver

    HL grant. $249,000. PI: Lisandra Flores Aldama

    full page →nih reporter ↗
    ›Feb 16, 2026grant178d agoSTANFORD UNIVERSITY — Development of Self-Assembling Pyrrole-Imidazole Polyamides for the Treatment...Stanford University

    GM grant. $75,880. PI: Kevin Jaime Gonzalez

    full page →nih reporter ↗
    ›Feb 16, 2026grant178d agoUNIV OF MASSACHUSETTS MED SCH WORCESTER — Role of TNF signaling in CX3CR1hi macrophages in the regulation of TLS function

    DK grant. $75,520. PI: Katherine Lauren Kruckow

    full page →nih reporter ↗
    ›Feb 16, 2026grant178d agoUNIVERSITY OF MINNESOTA — Stromal regulation of pathological bone remodelingUniversity of Minnesota

    DK grant. $676,905. PI: Hai-Bin Ruan

    full page →nih reporter ↗
    ›Feb 16, 2026grant178d agoJOHNS HOPKINS UNIVERSITY — Social Context, Community Norms, and Adolescent Girls' Sexual Health and Well...Johns Hopkins University

    HD grant. $49,538. PI: Charlotte Greenbaum

    full page →nih reporter ↗
    ›Feb 16, 2026grant178d agoUT SOUTHWESTERN MEDICAL CENTER — Tachycardia-induced Metabolic Remodeling Drives Cardiac Dysfunction

    HL grant. $249,000. PI: Chengyi Tu

    full page →nih reporter ↗
    ›Feb 16, 2026grant178d agoPENNSYLVANIA STATE UNIVERSITY, THE — Evolutionary and drug resistance landscape of human tyrosine kinases

    HG grant. $806,828. PI: David Martin McCandlish

    full page →nih reporter ↗
    ›Feb 16, 2026grant178d agoOKLAHOMA STATE UNIVERSITY STILLWATER — Manipulating interferon levels toward a safe and effective live single-cycle ...

    AI grant. $403,320. PI: Antonius G Oomens

    full page →nih reporter ↗
    ›Feb 17, 2026approval177d agoBOSENTAN — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET, FOR SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Feb 17, 2026approval177d agoGABAPENTIN — FDA approvalSciegen Pharmaceuticals Inc

    Sponsor: SCIEGEN PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 17, 2026approval177d agoIDELALISIB — FDA approvalIDELALISIB

    Sponsor: NATCO. Form: TABLET. Route: ORAL

    full page →IDELALISIB →fda approvals ↗
    ›Feb 17, 2026approval177d agoAMBRISENTAN — FDA approvalAMBRISENTAN

    Sponsor: WATSON LABS INC. Form: TABLET. Route: ORAL

    full page →AMBRISENTAN →fda approvals ↗
    ›Feb 17, 2026approval177d agoTELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Feb 17, 2026approval177d agoTELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Feb 17, 2026approval177d agoTELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Feb 17, 2026approval177d agoTELMISARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Feb 17, 2026approval177d agoSODIUM PHENYLBUTYRATE — FDA approvalSODIUM PHENYLBUTYRATE

    Sponsor: NAVINTA LLC. Form: TABLET. Route: ORAL

    full page →SODIUM PHENYLBUTYRATE →fda approvals ↗
    ›Feb 17, 2026approval177d agoDEXMEDETOMIDINE HYDROCHLORIDE — FDA approvalDEXMEDETOMIDINE HYDROCHLORIDE

    Sponsor: TAGI. Form: INJECTABLE. Route: INJECTION

    full page →DEXMEDETOMIDINE HYDROCHLORIDE →fda approvals ↗
    ›Feb 17, 2026approval177d agoCOLCHICINE — FDA approvalCOLCHICINE

    Sponsor: MICRO LABS. Form: CAPSULE. Route: ORAL

    full page →COLCHICINE →fda approvals ↗
    ›Feb 17, 2026approval177d agoAMBRISENTAN — FDA approvalAMBRISENTAN

    Sponsor: SIGMAPHARM LABS LLC. Form: TABLET. Route: ORAL

    full page →AMBRISENTAN →fda approvals ↗
    ›Feb 17, 2026approval177d agoMEDICAL AIR, USP — FDA approval

    Sponsor: INDUSTRIAL WELDING SUPPLY CO OF HARVEY INC. Form: GAS. Route: INHALATION

    full page →fda approvals ↗
    ›Feb 17, 2026approval177d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval177d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval177d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval177d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval177d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval177d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval177d agoAMPICILLIN AND SULBACTAM (AMPICILLIN SODIUM) — FDA approvalUNASYN

    Sponsor: ACS DOBFAR. Form: INJECTABLE. Route: INJECTION

    full page →UNASYN →fda approvals ↗
    ›Feb 17, 2026approval177d agoLOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Feb 17, 2026approval177d agoNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE (ETHINYL ESTRADIOL) — FDA approvalNORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE

    Sponsor: APOTEX. Form: TABLET. Route: ORAL

    full page →NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE →fda approvals ↗
    ›Feb 17, 2026approval177d agoMETRONIDAZOLE — FDA approvalMETRONIDAZOLE

    Sponsor: ALEMBIC. Form: GEL. Route: TOPICAL

    full page →METRONIDAZOLE →fda approvals ↗
    ›Feb 17, 2026approval177d agoMETRONIDAZOLE — FDA approvalMETRONIDAZOLE

    Sponsor: ALEMBIC. Form: GEL. Route: TOPICAL

    full page →METRONIDAZOLE →fda approvals ↗
    ›Feb 17, 2026approval177d agoRELGAABI (GABAPENTIN) — FDA approvalSciegen Pharmaceuticals Inc

    Sponsor: SCIEGEN PHARMS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 17, 2026approval177d agoANAGRELIDE HYDROCHLORIDE — FDA approvalTakeda Pharmaceuticals USA Inc

    Sponsor: WATSON LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 17, 2026approval177d agoAMLODIPINE BESYLATE — FDA approvalGraviti Pharmaceuticals Inc

    Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 17, 2026approval177d agoMEROPENEM — FDA approvalMEROPENEM

    Sponsor: QILU. Form: INJECTABLE. Route: INJECTION

    full page →MEROPENEM →fda approvals ↗
    ›Feb 17, 2026device 510k177d agoBiomendex OY — Adaptos®Fuse Bone Graft (510k cleared)

    Product code: MQV. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 17, 2026device 510k177d agoLiquet Medical, Inc. — Versus™ Catheter (VS110-9NB) (510k cleared)

    Product code: QEY. Advisory committee: Cardiovascular. Type: Special

    full page →fda device 510k ↗
    ›Feb 17, 2026device 510k177d agoJiangsu Yuyue Medical Equipment & Supply Co., Ltd. — YUWELL® Finger Pulse Oximeter (YX105, YX106, YX110, YX310) (510k cleared)

    Product code: DQA. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 17, 2026device 510k177d agoBiocomposites, Ltd. — Biosteon® Screw (510k cleared)

    Product code: MAI. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ← prev
    page 13 of 176
    next →